BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the recipient of a significant decline in short interest during the month of January. As of January 15th, there was short interest totalling 48,200 shares, a decline of 61.2% from the December 31st total of 124,200 shares. Based on an average trading volume of 365,000 shares, the days-to-cover ratio is presently 0.1 days.
Institutional Trading of BlackRock Health Sciences Term Trust
A number of institutional investors and hedge funds have recently modified their holdings of BMEZ. Penserra Capital Management LLC acquired a new position in BlackRock Health Sciences Term Trust during the 3rd quarter valued at $15,390,000. Stifel Financial Corp raised its stake in BlackRock Health Sciences Term Trust by 2.2% during the 3rd quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after purchasing an additional 8,843 shares during the last quarter. Absolute Investment Advisers LLC acquired a new position in BlackRock Health Sciences Term Trust during the 4th quarter valued at $3,941,000. Sanctuary Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust in the 2nd quarter valued at $3,179,000. Finally, Oppenheimer & Co. Inc. increased its holdings in BlackRock Health Sciences Term Trust by 0.6% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after buying an additional 1,153 shares during the period.
BlackRock Health Sciences Term Trust Price Performance
NYSE BMEZ traded down $0.14 during trading on Friday, reaching $16.46. The company’s stock had a trading volume of 307,739 shares, compared to its average volume of 536,397. The business has a 50-day moving average price of $15.40 and a 200-day moving average price of $15.64. BlackRock Health Sciences Term Trust has a 1-year low of $14.27 and a 1-year high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Company Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Nebius Group: Market Overreaction or Real AI Disruption?
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Best Way to Invest in Gold Is…
- Do ETFs Pay Dividends? What You Need to Know
- Why Nike Stock Could Be 2025’s Top Comeback Play
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.